Scott Jeffers
Seminars
Wednesday 25th February 2026
Breaking the Cost Barrier in Gene Therapy Manufacturing: Rethinking COGs to Enable Sustainable Commercialization
8:30 am
- Discussing why COGs, not efficacy, may be the greatest barrier to gene therapy adoption
- Sharing lessons from current commercial products: what the numbers really tell us about cost, pricing, and scalability
- Identifying high-impact levers for cost reduction across upstream, downstream, and release processes
- Bridging innovation and economics: what types of investment and collaboration are needed to enable sustainable manufacturing
